Envestnet Asset Management Inc. Boosts Stock Position in U.S. Physical Therapy, Inc. (NYSE:USPH)

Envestnet Asset Management Inc. lifted its stake in shares of U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 5.6% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 316,489 shares of the company's stock after buying an additional 16,698 shares during the period. Envestnet Asset Management Inc. owned about 2.08% of U.S. Physical Therapy worth $22,901,000 at the end of the most recent quarter.

Other hedge funds also recently modified their holdings of the company. HighTower Advisors LLC lifted its holdings in U.S. Physical Therapy by 2.5% during the fourth quarter. HighTower Advisors LLC now owns 4,833 shares of the company's stock worth $429,000 after acquiring an additional 119 shares during the period. Portside Wealth Group LLC lifted its holdings in U.S. Physical Therapy by 3.9% during the first quarter. Portside Wealth Group LLC now owns 4,108 shares of the company's stock worth $297,000 after acquiring an additional 154 shares during the period. Precision Wealth Strategies LLC lifted its holdings in U.S. Physical Therapy by 6.6% during the first quarter. Precision Wealth Strategies LLC now owns 3,054 shares of the company's stock worth $221,000 after acquiring an additional 189 shares during the period. Aquatic Capital Management LLC lifted its holdings in U.S. Physical Therapy by 18.0% during the fourth quarter. Aquatic Capital Management LLC now owns 1,298 shares of the company's stock worth $115,000 after acquiring an additional 198 shares during the period. Finally, Bessemer Group Inc. lifted its holdings in U.S. Physical Therapy by 4.4% during the first quarter. Bessemer Group Inc. now owns 4,929 shares of the company's stock worth $357,000 after acquiring an additional 208 shares during the period.

Insider Buying and Selling

In related news, Director Nancy Ham sold 400 shares of the business's stock in a transaction dated Thursday, June 12th. The stock was sold at an average price of $78.01, for a total transaction of $31,204.00. Following the completion of the transaction, the director directly owned 2,594 shares in the company, valued at $202,357.94. The trade was a 13.36% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 2.00% of the stock is currently owned by insiders.

U.S. Physical Therapy Stock Performance

Shares of NYSE USPH traded up $1.13 during mid-day trading on Thursday, hitting $74.86. The company had a trading volume of 61,455 shares, compared to its average volume of 124,793. U.S. Physical Therapy, Inc. has a 1 year low of $62.77 and a 1 year high of $101.20. The stock's 50-day moving average price is $76.75 and its 200-day moving average price is $78.73. The company has a current ratio of 1.17, a quick ratio of 1.17 and a debt-to-equity ratio of 0.32. The company has a market capitalization of $1.14 billion, a price-to-earnings ratio of 34.34, a P/E/G ratio of 3.55 and a beta of 1.44.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last posted its earnings results on Wednesday, May 7th. The company reported $0.48 EPS for the quarter, topping the consensus estimate of $0.46 by $0.02. U.S. Physical Therapy had a return on equity of 7.89% and a net margin of 4.57%. The business had revenue of $183.79 million during the quarter, compared to analysts' expectations of $176.78 million. During the same period in the previous year, the business earned $0.51 earnings per share. The firm's revenue was up 18.0% on a year-over-year basis. On average, sell-side analysts forecast that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current year.

U.S. Physical Therapy Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, June 13th. Investors of record on Friday, May 23rd were given a dividend of $0.45 per share. This represents a $1.80 annualized dividend and a yield of 2.40%. The ex-dividend date was Friday, May 23rd. U.S. Physical Therapy's payout ratio is 82.57%.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on USPH. JPMorgan Chase & Co. lowered their target price on U.S. Physical Therapy from $120.00 to $110.00 and set an "overweight" rating on the stock in a research note on Wednesday, March 19th. Barrington Research restated an "outperform" rating and issued a $98.00 target price on shares of U.S. Physical Therapy in a research note on Tuesday, July 1st. JMP Securities restated a "market outperform" rating and issued a $113.00 target price on shares of U.S. Physical Therapy in a research note on Tuesday, April 22nd. Finally, Wall Street Zen upgraded U.S. Physical Therapy from a "sell" rating to a "hold" rating in a research report on Thursday, May 8th. Two research analysts have rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, U.S. Physical Therapy has an average rating of "Moderate Buy" and an average price target of $109.00.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.